Acquiring expert clinical insights and perspectives is critical throughout the lifecycle of a drug. Those insights often revolve around patient-centric topics such as differences in regional care, therapeutic treatment protocols, and preliminary diagnostic testing. The findings often serve to have cross-organizational impact – shaping both medical affairs and commercial team decision-making and related efforts.
A leading pharmaceutical organization’s medical affairs team was purposed with acquiring multi-touchpoint feedback about these types of patient-centric topics on the subject of lymphatic blood-based cancer.
This case study examines how they took an innovative approach to achieving the necessary engagement outcomes.
A big plus was that we saved at least 60% in our budget compared to a live ad board – management will be pleased.Medical Affairs Lead Moderator